Price T Rowe Associates Inc. MD Increases Stock Holdings in Vital Farms, Inc. (NASDAQ:VITL)

Price T Rowe Associates Inc. MD boosted its holdings in shares of Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 56.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 662,174 shares of the company's stock after acquiring an additional 239,552 shares during the period. Price T Rowe Associates Inc. MD owned 1.51% of Vital Farms worth $24,958,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of VITL. Barclays PLC grew its position in shares of Vital Farms by 57.3% in the third quarter. Barclays PLC now owns 95,444 shares of the company's stock valued at $3,347,000 after purchasing an additional 34,758 shares in the last quarter. Franklin Resources Inc. grew its holdings in Vital Farms by 10.2% in the 3rd quarter. Franklin Resources Inc. now owns 372,583 shares of the company's stock valued at $13,066,000 after buying an additional 34,412 shares in the last quarter. Principal Financial Group Inc. increased its stake in shares of Vital Farms by 35.6% in the 3rd quarter. Principal Financial Group Inc. now owns 655,811 shares of the company's stock worth $22,999,000 after acquiring an additional 172,249 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Vital Farms by 38.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 266,398 shares of the company's stock worth $9,343,000 after acquiring an additional 74,593 shares during the period. Finally, Nordea Investment Management AB acquired a new position in shares of Vital Farms during the 4th quarter valued at about $2,765,000. Institutional investors and hedge funds own 98.59% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on VITL. Stifel Nicolaus raised shares of Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 target price on the stock in a research note on Friday, February 28th. Morgan Stanley reduced their price target on shares of Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a research report on Thursday, April 17th. Telsey Advisory Group reiterated an "outperform" rating and issued a $52.00 price objective on shares of Vital Farms in a research report on Thursday, March 13th. William Blair reaffirmed an "outperform" rating on shares of Vital Farms in a research note on Friday, February 28th. Finally, TD Cowen increased their price target on Vital Farms from $41.00 to $45.00 and gave the stock a "buy" rating in a report on Wednesday, January 8th. Eight analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of $44.71.

Insider Transactions at Vital Farms

In other Vital Farms news, CEO Russell Diez-Canseco sold 45,124 shares of the company's stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $33.69, for a total transaction of $1,520,227.56. Following the sale, the chief executive officer now owns 703,736 shares in the company, valued at $23,708,865.84. This represents a 6.03 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Matthew Ohayer sold 24,000 shares of Vital Farms stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $32.68, for a total value of $784,320.00. Following the completion of the transaction, the insider now owns 6,942,890 shares of the company's stock, valued at $226,893,645.20. The trade was a 0.34 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 93,124 shares of company stock valued at $3,019,308. 27.60% of the stock is currently owned by company insiders.

Vital Farms Trading Up 2.0 %

Shares of NASDAQ VITL traded up $0.70 during trading on Friday, reaching $35.77. The stock had a trading volume of 718,104 shares, compared to its average volume of 1,042,967. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.81 and a current ratio of 3.24. The company has a market cap of $1.59 billion, a P/E ratio of 31.94 and a beta of 0.96. Vital Farms, Inc. has a fifty-two week low of $27.91 and a fifty-two week high of $48.41. The business's 50-day moving average price is $32.23 and its 200-day moving average price is $35.20.

Vital Farms (NASDAQ:VITL - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.15 by $0.08. Vital Farms had a net margin of 8.68% and a return on equity of 22.29%. The company had revenue of $165.99 million for the quarter, compared to analyst estimates of $160.32 million. On average, equities research analysts predict that Vital Farms, Inc. will post 1.11 EPS for the current fiscal year.

Vital Farms Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.